[Shifts in coagulating and fibrinolytic activity of the blood following the administration of nerobol in patients with coronary atherosclerosis].
D000368:Aged; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy; D001777:Blood Coagulation / Q000187:drug effects*; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005340:Fibrinogen; D005342:Fibrinolysis / Q000187:drug effects; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008696:Methandrostenolone / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D011516:Prothrombin
D011516:Prothrombin; D005340:Fibrinogen; D006493:Heparin; D008696:Methandrostenolone
Sdvigi v koaguliruiushcheĭ i fibrinoliticheskoĭ aktivnosti krovi pri primenenii nerobola u bol'nykh koronarnym aterosklerozom.